Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

LPL Receptor

The lysophospholipid receptor (LPL-R) group are members of the G protein-coupled receptor family of integral membrane proteins that are important for lipid signaling. In humans, there are eight LPL receptors, each encoded by a separate gene. These LPL receptor genes are also sometimes referred to as "Edg" (an acronym for endothelial differentiation gene).

Sphingosine-1-phosphate
T2150026993-30-6
Sphingosine-1-phosphate (S1P) is an agonist for S1P1-5 receptors and a ligand for GPR3, GPR6, and GPR12. As an intracellular second messenger, it mobilizes Ca2+ and acts as an extracellular ligand for G-protein coupled receptors. This important lipid mediator is generated from sphingosine or other membrane phospholipids.
  • $299
In Stock
Size
QTY
JTE-013
T15629383150-41-2
JTE-013 is an effective and specific antagonist of S1P2. JTE-013 suppresses the specific binding of radiolabeled S1P to human and rat S1P2 (IC50s: 17 nM and 22 nM, respectively).
  • $70
In Stock
Size
QTY
Ozanimod
T69231306760-87-1
Ozanimod (RPC-1063) (RPC1063) is a specific oral S1P Receptor 1 modulator. Ozanimod has been used in trials studying the treatment of Crohn's Disease, Ulcerative Colitis, Multiple Sclerosis, and Relapsing Multiple Sclerosis.
  • $41
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Etrasimod
TQ02271206123-37-6
Etrasimod (APD334) is a specific and orally available antagonist of the sphingosine-1-phosphate-1 (S1P1) receptor (IC50: 1.88 nM in CHO cells).
  • $48
In Stock
Size
QTY
TargetMol | Inhibitor Sale
Fingolimod hydrochloride
T2539162359-56-0
Fingolimod hydrochloride (FTY720) , a novel immune modulator, is a sphingosine 1-phosphate (S1P) antagonist (IC50: 0.033 nM in K562 and NK cells).
  • $35
In Stock
Size
QTY
W146
T13327909725-61-7
W146 is a selective and potent Sphingosine 1-phosphate receptor subtype 1 (S1PR1) antagonist that induces significant but transient hematolymphopenia in mice.W146 induces significant but transient hematolymphopenia in mice, inducing pulmonary edema.
  • $165
In Stock
Size
QTY
Ponesimod
T3258854107-55-4
Ponesimod (ACT-128800) is an orally available sphingosine-1-phosphate receptor 1 (S1PR1, S1P1) agonist with potential immunomodulating activity.
  • $38
In Stock
Size
QTY
TargetMol | Citations Cited
Mocravimod hydrochloride
T12086509088-69-1
Mocravimod hydrochloride (KRP-203) is an effecitive and orally active agonist of sphingosine 1-phosphate receptor type 1(S1PR1).
  • $64
In Stock
Size
QTY
NIBR-0213
T281691233332-14-3
NIBR-0213 is a potent and selective competitive S1P1 antagonist with activity against experimental autoimmune encephalomyelitis. In the GTPγ35S assay, it has IC50 values ​​of 2.0 nM and 2.3 nM for human and rat S1P1, respectively.
  • $35
In Stock
Size
QTY
Siponimod
T64031230487-00-9
BAF312 (Siponimod (BAF-312)), a next-generation S1P receptor modulator, is specific for S1P1 and S1P5 receptors with EC50 of 0.39 nM and 0.98 nM, respectively. The specificity of BAF312 for S1P1 and S1P5 receptors exhibits >1000-fold over S1P2, S1P3 and S1P4 receptors.
  • $33
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
H2L 5765834
T22834420841-84-5
H2L 5765834 is a lysophosphatidic acid receptors antagonist
  • $56
In Stock
Size
QTY
TargetMol | Inhibitor Sale
S1PR1 modulator 1
T128212328109-05-1In house
S1PR1 modulator 1 is a selective inhibitor of S1PR1, with a pIC50 of 7.6.
  • $59
In Stock
Size
QTY
SEW​2871
T2171256414-75-2
SEW 2871 is an orally available, highly selective S1P1 agonist with an EC50 of 13.8 nM.It reduces the number of lymphocytes in the blood and is used in studies related to diabetes, Alzheimer's disease, liver fibrosis, and inflammation. It activates ERK, Akt and Rac signaling pathways and induces S1P1 internalization and recycling.
  • $48
In Stock
Size
QTY
TargetMol | Inhibitor Hot
AM966
T42781228690-19-4
AM966, a excellent affinity, specific, oral LPA1(IC50=17 nM) antagonist, suppresses LPA-stimulated intracellular calcium release.
  • $33
In Stock
Size
QTY
TargetMol | Inhibitor Sale
CYM5442
T20261094042-01-9
CYM5442 is an S1P agonist, targeting to Sphingosine.
  • $39
In Stock
Size
QTY
TargetMol | Citations Cited
Ki16425
T6108355025-24-0
Ki16425 (Debio 0719) is a competitive, potent, and reversible antagonist to LPA1, LPA2, and LPA3, with Ki values of 0.34 μM, 6.5 μM, and 0.93 μM, respectively.
  • $35
In Stock
Size
QTY
BMS-986020
T40161257213-50-5
BMS-986020 (AM152) is a selective LPA1 antagonist.
  • $47
In Stock
Size
QTY
PF-543 hydrochloride
T88401706522-79-3
PF-543 hydrochloride (PF-543) inhibits SphK1 with a K(i) of 3.6 nM, is sphingosine-competitive and is more than 100-fold selective for SphK1 over the SphK2 isoform.
  • $33
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
CYM-5520
T227031449747-00-5
CYM-5520 is a noncompetitive allosteric agonist of S1P2
  • $40
In Stock
Size
QTY
CYM50358
T94641314212-39-9
N-(4-(aminomethyl)-2,6-dimethylphenyl)-5 is a potent, selective antagonist of the sphingosine-1-phosphate receptor 4 (S1P4). CYM50358 inhibits S1P4 with an IC50 of 25 nM.
  • $51
In Stock
Size
QTY
Tyloxapol
T030725301-02-4
Tyloxapol (Triton WR1339) is a non-ionic liquid polymer utilized as a surfactant.
  • $30
In Stock
Size
QTY
TargetMol | Citations Cited
SLF1081851
T611122763730-97-6
SLF1081851 is a Spns2 inhibitor. SLF1081851 inhibits S1P release with IC50 of 1.93 μM.
  • $51
In Stock
Size
QTY
SLP9101555
T63047 In house
SLP9101555 is a potent and selective sphingosine kinase 2 (SphK2) inhibitor with a Ki of 90 nM.SLP9101555 has a high affinity for SphK2, which is 200-fold higher than that of SphK1.SLP9101555 dramatically reduces extracellular S1P sphingosine 1-phosphate (S1P) levels.
  • $350
In Stock
Size
QTY
Ibrolipim
T7832133208-93-2
Ibrolipim (NO-1886) attenuates high glucose-induced endothelial dysfunction in cultured human umbilical vein endothelial cells via PI3K Akt pathway.
  • $43
In Stock
Size
QTY
CYM50308
T150321345858-76-5
CYM50308 is a high affinity agonist of sphingosine-1-phosphate receptor 4 (S1P4-R) (EC50: 56 nM). CYM50308 has no activity at S1P1-R, S1P2-R and S1P3-R subtypes at concentrations up to 25 μM and it shows 37-fold more selective for S1P4-R than S1P5-R.
  • $56
In Stock
Size
QTY
CYM-5541
T3961945128-26-7
CYM-5541 (ML249) is a selective and allosteric S1P3 receptor agonist.
  • $32
In Stock
Size
QTY
S1p receptor agonist 1
T40311514888-56-2
S1p receptor agonist 1 (S1p-receptor-agonist-1) is an S1P receptor agonist.
  • $39
In Stock
Size
QTY
Amiselimod hydrochloride
T10305942398-84-7
Amiselimod hydrochloride (MT-1303 hydrochloride) is a sphingosine 1-phosphate receptor-1 (S1P1) modulator.
  • $32
In Stock
Size
QTY
TY-52156
T17183934369-14-9
TY-52156 is an effective and selective S1P3 receptor antagonist (Ki: 110 nM).
  • $34
In Stock
Size
QTY
ASP-4058
T10385952565-91-2In house
ASP-4058 is a selective, safe, and orally active second-generation agonist of sphingosine phosphate receptors 1 and 5 (S1P1 and S1P5).ASP-4058 ameliorates experimental autoimmune encephalomyelitis in mice.
  • $100
In Stock
Size
QTY
CYM50260
T150311355026-60-6In house
CYM50260 is a potent and highly selective agonist of the sphingosine-1-phosphate 4 receptor (S1P4-R, EC50= nM), exhibiting no activity against S1P1-R, S1P2-R, S1P3-R, and S1P5-R.
  • $48
In Stock
Size
QTY
GSK2018682
T73601034688-30-6
GSK2018682 is an agonist of sphingosine-1-phosphate receptor (s1p1) and (s1p5) agonist(pEC50s of 7.7 and 7.2,respectively).
  • $30
In Stock
Size
QTY
AM095 free acid
T102931228690-36-5
AM095 (free acid) is a potent LPA1 receptor antagonist with IC50 values of 0.98 μM for recombinant human LPA1 and 0.73 μM for recombinant mouse LPA1.
  • $33
In Stock
Size
QTY
GLPG2938
T91992130996-00-6
GLPG2938 (1-(2-Ethoxy-6-(trifluoromethyl)pyridin-4-yl)-3-((5-methyl-6-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)pyridazin-3-yl)methyl)urea) is a potent and selective antagonist of S1P2.
  • $76
In Stock
Size
QTY
PF-543
T60851415562-82-1
PF-543 (Sphingosine Kinase 1 Inhibitor II), a novel sphingosine-competitive inhibitor of SphK1, inhibits SphK1 with IC50 of 2.0 nM and Ki of 3.6 nM.
  • $46
In Stock
Size
QTY
TargetMol | Citations Cited
Ki16198
T6347355025-13-7
Ki16198 is an orally available LPA receptor antagonist and is a methyl ester derivative of Ki16425. It inhibits LPA1- and LPA3-induced inositol phosphates with Ki values of 0.34 and 0.93 μM, respectively, and can be used in studies of pancreatic carcinogenesis and metastasis.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Sale
AM095
T20001345614-59-6
AM095 is a potent LPA1 receptor antagonist with IC50 values of 0.98 and 0.73 μM for recombinant human or mouse LPA1 respectively.
  • $41
In Stock
Size
QTY
TargetMol | Inhibitor Sale
ONO-7300243
T7393638132-34-0
ONO-7300243 is an antagonist of lysophosphatidic acid receptor 1 (LPA1; IC50 : 0.16 µM).
  • $38
In Stock
Size
QTY
TargetMol | Inhibitor Sale
1-Oleoyl Lysophosphatidic Acid
T3690765528-98-5
1-Oleoyl Lysophosphatidic Acid (1-Oleoyl LPA) is a biologically active phospholipid that can exert multiple biological effects in various disease states of the kidney by activating a complex network of at least six homologous G protein-coupled receptors and their heterotrimeric G proteins. 1-Oleoyl Lysophosphatidic Acid promotes polarization of BV-2 and primary murine microglia toward an M1-like phenotype and can be used to study cancer and atherosclerosis.
  • $65
35 days
Size
QTY
Sonepcizumab
T768281031360-18-5
Sonepcizumab (LT 1009) is a fully humanized monoclonal antibody against S1P, with anti-cancer activity, useful for studying metastatic renal cell carcinoma (mRCC) and preventing eye scarring after glaucoma filtration surgery.
  • $289
In Stock
Size
QTY
Spns2-IN-1
T81114
Spns2-IN-1 is a potent Spns2 inhibitor, effectively impeding Spns2-dependent S1P transport with an IC50 value of 1.4±0.3 μM, crucial for modulating the immune response [1].
  • Inquiry Price
Size
QTY
SLB1122168 formic
T78160
SLB1122168 is a potent inhibitor of Spns2-mediated sphingosine-1-phosphate (S1P) release, exhibiting an IC50 value of 94 nM [1].
  • $130
5 days
Size
QTY
S1P1 agonist 6 hemicalcium
T798172941310-03-6
Compound I (S1P1 agonist 6 hemicalcium) is an S1P1 agonist that diminishes autoimmune activity by inhibiting lymphocyte trafficking, and serves as an immunosuppressive agent in researching a range of autoimmune diseases [1].
  • Inquiry Price
8-10 weeks
Size
QTY
(S)-FTY720-phosphonate
T780911142015-10-8
FTY720 (S)-Phosphate, an S1P receptor 1 (S1PR1) agonist, is utilized in studying acute inflammatory diseases, including acute lung injury.
  • Inquiry Price
8-10 weeks
Size
QTY
S1P1 agonist 6
T798162433782-42-2
Compound I (S1P1 agonist 6) is an S1P1 agonist that mitigates autoimmune activity by inhibiting lymphocyte trafficking and has potential as an immunosuppressive agent in autoimmune disease research [1].
  • Inquiry Price
8-10 weeks
Size
QTY
VPC 23019
T17237449173-19-7
VPC 23019 is a competitive antagonist at the S1P1 and S1P3 receptors (pKi= 7.86 and 5.93, respectively). It is also an agonist at the S1P4 and S1P5 receptors (pEC50= 6.58 and 7.07, respectively).
  • $664
6-8 weeks
Size
QTY